Rare (less than 0.1%): Antibody development
Postmarketing reports: Hemolytic anemia, autoimmune hemolytic anemia, thrombocythemia, thrombocytopenia, autoimmune thrombocytopenia
Postmarketing reports: Lymphomas
Postmarketing reports: Urticaria
Frequency not reported: Headache
Frequency not reported: Injection site pain, injection site erythema
Back, leg, or stomach pains
bleeding gums
chills
dark urine
difficulty breathing
dizziness
fever
general body swelling
headache
loss of appetite
nausea or vomiting
nosebleeds
pain, warmth, or burning in the fingers, toes, and legs
pale skin
problems with vision or hearing
sore throat
unusual tiredness or weakness
yellowing of the eyes or skin
Hives or welts
itching
redness of skin
redness or pain at the site of injection
skin rash